Insider Trading & Ownership - Giordano Natasha

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Giordano Natasha
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-03-15
Purchase
2022-03-16
08:35 am
PLx Pharma Inc.PLXPGiordano Natasha
Chief Executive Officer
4,100$3.6529$14,9775,186
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-11-01
Option Award
2023-11-03
4:49 pm
N/A
2033-11-01
Matinas BioPharma Holdings Inc.MTNBGiordano Natasha
Director
437,244$0437,244
(Direct)
View
2022-11-14
Option Award
2022-11-16
9:36 pm
N/A
2032-11-14
Matinas BioPharma Holdings Inc.MTNBGiordano Natasha
Director
142,657$0142,657
(Direct)
View
2022-02-22
Option Award
2022-02-24
8:13 pm
N/A
2032-02-22
PLx Pharma Inc.PLXPGiordano Natasha
Chief Executive Officer
300,000$0300,000
(Direct)
View
2021-11-01
Option Award
2021-11-02
4:22 pm
N/A
2031-11-01
Matinas BioPharma Holdings Inc.MTNBGiordano Natasha
Director
90,882$090,882
(Direct)
View
2021-08-09
Option Award
2021-08-11
09:01 am
N/A
2031-08-09
PLx Pharma Inc.PLXPGiordano Natasha
Chief Executive Officer
200,000$0200,000
(Direct)
View
2020-11-18
Option Award
2020-11-20
7:39 pm
N/A
2030-11-18
PLx Pharma Inc.PLXPGiordano Natasha
Chief Executive Officer
350,000$0350,000
(Direct)
View

Ownership
2020-09-15
4:48 pm
N/A
2030-09-10
Matinas BioPharma Holdings Inc.MTNBGiordano Natasha
Director
0$0287,917
(Direct)
View
2020-03-20
Option Award
2020-03-24
8:52 pm
N/A
2030-03-20
PLx Pharma Inc.PLXPGiordano Natasha
Chief Executive Officer
175,000$0175,000
(Direct)
View